Calcific aortic valve disease: A consensus summary from the alliance of investigators on calcific aortic valve disease

Katherine E. Yutzey, Linda L. Demer, Simon C. Body, Gordon S. Huggins, Dwight A. Towler, Cecilia M. Giachelli, Marion A. Hofmann-Bowman, Douglas P. Mortlock, Melissa B. Rogers, Mehran M. Sadeghi, Elena Aikawa

Research output: Contribution to journalReview article

95 Citations (Scopus)

Abstract

Calcific aortic valve disease (CAVD) is increasingly prevalent worldwide with significant morbidity and mortality. Therapeutic options beyond surgical valve replacement are currently limited. In 2011, the National Heart Lung and Blood Institute assembled a working group on aortic stenosis. This group identified CAVD as an actively regulated disease process in need of further study. As a result, the Alliance of Investigators on CAVD was formed to coordinate and promote CAVD research, with the goals of identifying individuals at risk, developing new therapeutic approaches, and improving diagnostic methods. The group is composed of cardiologists, geneticists, imaging specialists, and basic science researchers. This report reviews the current status of CAVD research and treatment strategies with identification of areas in need of additional investigation for optimal management of this patient population.

Original languageEnglish (US)
Pages (from-to)2387-2393
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

Aortic Diseases
Aortic Valve
Research Personnel
National Heart, Lung, and Blood Institute (U.S.)
Aortic Valve Stenosis
Research
Surgical Instruments
Therapeutics
Morbidity
Mortality
Population

Keywords

  • Aortic valve stenosis
  • Calcification
  • Inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Calcific aortic valve disease : A consensus summary from the alliance of investigators on calcific aortic valve disease. / Yutzey, Katherine E.; Demer, Linda L.; Body, Simon C.; Huggins, Gordon S.; Towler, Dwight A.; Giachelli, Cecilia M.; Hofmann-Bowman, Marion A.; Mortlock, Douglas P.; Rogers, Melissa B.; Sadeghi, Mehran M.; Aikawa, Elena.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 34, No. 11, 01.11.2014, p. 2387-2393.

Research output: Contribution to journalReview article

Yutzey, KE, Demer, LL, Body, SC, Huggins, GS, Towler, DA, Giachelli, CM, Hofmann-Bowman, MA, Mortlock, DP, Rogers, MB, Sadeghi, MM & Aikawa, E 2014, 'Calcific aortic valve disease: A consensus summary from the alliance of investigators on calcific aortic valve disease', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 11, pp. 2387-2393. https://doi.org/10.1161/ATVBAHA.114.302523
Yutzey, Katherine E. ; Demer, Linda L. ; Body, Simon C. ; Huggins, Gordon S. ; Towler, Dwight A. ; Giachelli, Cecilia M. ; Hofmann-Bowman, Marion A. ; Mortlock, Douglas P. ; Rogers, Melissa B. ; Sadeghi, Mehran M. ; Aikawa, Elena. / Calcific aortic valve disease : A consensus summary from the alliance of investigators on calcific aortic valve disease. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2014 ; Vol. 34, No. 11. pp. 2387-2393.
@article{78d73ebd5e4042d9988792c4542f7ed7,
title = "Calcific aortic valve disease: A consensus summary from the alliance of investigators on calcific aortic valve disease",
abstract = "Calcific aortic valve disease (CAVD) is increasingly prevalent worldwide with significant morbidity and mortality. Therapeutic options beyond surgical valve replacement are currently limited. In 2011, the National Heart Lung and Blood Institute assembled a working group on aortic stenosis. This group identified CAVD as an actively regulated disease process in need of further study. As a result, the Alliance of Investigators on CAVD was formed to coordinate and promote CAVD research, with the goals of identifying individuals at risk, developing new therapeutic approaches, and improving diagnostic methods. The group is composed of cardiologists, geneticists, imaging specialists, and basic science researchers. This report reviews the current status of CAVD research and treatment strategies with identification of areas in need of additional investigation for optimal management of this patient population.",
keywords = "Aortic valve stenosis, Calcification, Inflammation",
author = "Yutzey, {Katherine E.} and Demer, {Linda L.} and Body, {Simon C.} and Huggins, {Gordon S.} and Towler, {Dwight A.} and Giachelli, {Cecilia M.} and Hofmann-Bowman, {Marion A.} and Mortlock, {Douglas P.} and Rogers, {Melissa B.} and Sadeghi, {Mehran M.} and Elena Aikawa",
year = "2014",
month = "11",
day = "1",
doi = "10.1161/ATVBAHA.114.302523",
language = "English (US)",
volume = "34",
pages = "2387--2393",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Calcific aortic valve disease

T2 - A consensus summary from the alliance of investigators on calcific aortic valve disease

AU - Yutzey, Katherine E.

AU - Demer, Linda L.

AU - Body, Simon C.

AU - Huggins, Gordon S.

AU - Towler, Dwight A.

AU - Giachelli, Cecilia M.

AU - Hofmann-Bowman, Marion A.

AU - Mortlock, Douglas P.

AU - Rogers, Melissa B.

AU - Sadeghi, Mehran M.

AU - Aikawa, Elena

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Calcific aortic valve disease (CAVD) is increasingly prevalent worldwide with significant morbidity and mortality. Therapeutic options beyond surgical valve replacement are currently limited. In 2011, the National Heart Lung and Blood Institute assembled a working group on aortic stenosis. This group identified CAVD as an actively regulated disease process in need of further study. As a result, the Alliance of Investigators on CAVD was formed to coordinate and promote CAVD research, with the goals of identifying individuals at risk, developing new therapeutic approaches, and improving diagnostic methods. The group is composed of cardiologists, geneticists, imaging specialists, and basic science researchers. This report reviews the current status of CAVD research and treatment strategies with identification of areas in need of additional investigation for optimal management of this patient population.

AB - Calcific aortic valve disease (CAVD) is increasingly prevalent worldwide with significant morbidity and mortality. Therapeutic options beyond surgical valve replacement are currently limited. In 2011, the National Heart Lung and Blood Institute assembled a working group on aortic stenosis. This group identified CAVD as an actively regulated disease process in need of further study. As a result, the Alliance of Investigators on CAVD was formed to coordinate and promote CAVD research, with the goals of identifying individuals at risk, developing new therapeutic approaches, and improving diagnostic methods. The group is composed of cardiologists, geneticists, imaging specialists, and basic science researchers. This report reviews the current status of CAVD research and treatment strategies with identification of areas in need of additional investigation for optimal management of this patient population.

KW - Aortic valve stenosis

KW - Calcification

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84911913843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911913843&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.114.302523

DO - 10.1161/ATVBAHA.114.302523

M3 - Review article

C2 - 25189570

AN - SCOPUS:84911913843

VL - 34

SP - 2387

EP - 2393

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -